BLEGD (Branded Legacy) Equity-to-Asset: -15.59 (As of Dec. 2021)


What is Branded Legacy Equity-to-Asset?

Branded Legacy BLEGD Equity-to-Asset is -15.59 as of Dec. 2021.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Branded Legacy's Total Stockholders Equity for the quarter that ended in Dec. 2021 was $-1.87 Mil. Branded Legacy's Total Assets for the quarter that ended in Dec. 2021 was $0.12 Mil. Therefore, Branded Legacy's Equity to Asset Ratio for the quarter that ended in Dec. 2021 was -15.59.

The historical rank and industry rank for Branded Legacy's Equity-to-Asset or its related term are showing as below:

BLEGD's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.61
* Ranked among companies with meaningful Equity-to-Asset only.

Branded Legacy  (OTCPK:BLEGD) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Branded Legacy Equity-to-Asset Related Terms

Branded Legacy Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Branded Legacy's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Branded Legacy Equity-to-Asset Chart

Branded Legacy Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Equity-to-Asset
Get a 7-Day Free Trial -7.94 0.20 -7.23 -10.33 -15.59

Branded Legacy Quarterly Data
Dec15 Dec16 Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.33 -9.59 -10.46 -11.15 -15.59

BLEGD vs UPDC, RIBT, GDMK: Equity-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Branded Legacy's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Branded Legacy Equity-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Branded Legacy's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Branded Legacy's Equity-to-Asset falls into.


Branded Legacy Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Branded Legacy's Equity to Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Equity to Asset (A: Dec. 2021 )=Total Stockholders Equity/Total Assets
=-1.871/0.12
=-15.59

Branded Legacy's Equity to Asset Ratio for the quarter that ended in Dec. 2021 is calculated as

Equity to Asset (Q: Dec. 2021 )=Total Stockholders Equity/Total Assets
=-1.871/0.12
=-15.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of -15.59 mean?
Branded Legacy (BLEGD) has a Equity-to-Asset of -15.59 as of Dec. 2021. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Branded Legacy and its competitors.
Is Branded Legacy's Equity-to-Asset too high?
Branded Legacy's current Equity-to-Asset is -15.59.
How does Branded Legacy's Equity-to-Asset compare to UPDC and RIBT?
Branded Legacy's Equity-to-Asset of -15.59 can be compared against companies in the Drug Manufacturers industry. The industry median Equity-to-Asset is 0.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Branded Legacy and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Branded Legacy's current Equity-to-Asset is -15.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Branded Legacy stock overvalued right now?
Branded Legacy (BLEGD) has a current Equity-to-Asset of -15.59. The current Equity-to-Asset is -15.59. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Branded Legacy (BLEGD), the current Equity-to-Asset is -15.59 as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Branded Legacy Business Description

Address 751 North Drive, Suite 9, Melbourne, FL, USA, 32934
Branded Legacy Inc provides high-level strategic advisory and operational transformation services focused on complex research, clinical development, and data-intensive organizations. Branded Legacy specializes in supporting large-scale international research consortia, platform clinical trials, and institutional/government data science initiatives. The core operations center on diagnosing operational inefficiencies, redesigning legacy systems, and implementing transparent, high-impact solutions that deliver measurable results.